8-K 1 bivi-20190814_8k.htm CURRENT REPORT

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

     

 

FORM 8-K

     

 

CURRENT REPORT PURSUANT

TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported) August 12, 2019

 

BioVie Inc.

(Exact Name of Registrant as Specified in Its Charter)

         
Nevada   000-55292   46-2510769

(State or Other Jurisdiction

of Incorporation)

  (Commission File Number)   (I.R.S. Employer Identification No.)

 

2120 Colorado Avenue, #230

Santa Monica, California

  90404
(Address of Principal Executive Offices)   (Zip Code)

 

(310) 444-4300

(Registrant’s Telephone Number, Including Area Code)

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
     

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

[_]Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[_]Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[_]Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[_]Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company  

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. □

 

 
 
Item 8.01 Other Events.

 

On August 12, 2019, BioVie Inc., a Nevada corporation, filed a notice of termination regarding an amendment to its Articles of Incorporation intended to effect a reverse split of its Class A common stock as a result of its Board of Directors having determined not to proceed with the contemporaneous public offering and listing on the Nasdaq Capital Market due to market conditions at this time.

 

 -1-

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: August 14, 2019

 

  BIOVIE INC.
   
 

By:    /s/ Joanne Wendy Kim                                

Name: Joanne Wendy Kim

Title: Chief Financial Officer

 

 -2-